Synergy Between Vitamin D and Sex Hormones in Respiratory Functionality of Patients Affected by COVID-19.

SARS-CoV-2 gender sex differences sex hormones vitamin D

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2021
Historique:
received: 21 03 2021
accepted: 28 04 2021
entrez: 31 5 2021
pubmed: 1 6 2021
medline: 1 6 2021
Statut: epublish

Résumé

The outcome of COVID-19 appears to be influenced by vitamin D status of population. Although epidemiological data indicate that COVID-19 produces more severe symptoms and higher mortality in elderly in comparison to young patients and in men in comparison to women to date sex and age differences in vitamin D status in infected patients have not been evaluated yet. In this study we evaluated the levels of circulating 25(OH)D in patients hospitalized for COVID-19 divided accordingly to their sex and age. We also correlated 25(OH)D levels with patient's respiratory status (i.e., PaO2/FiO2 ratio) and with sex hormones plasma levels to analyze the potential relationship of these parameters. We found no significant differences in plasma levels of 25(OH)D between pre- and post-menopausal female patients and age matched male patients. Interestingly, the 25(OH)D plasma levels positively correlated to PaO2/FiO2 ratio only in young patients, regardless of their sex. We also found a significantly positive correlation between 17β-estradiol and 25(OH)D in elderly women and between testosterone and 25(OH)D in elderly men, supporting the role of sex hormones in maintaining 25(OH)D levels. In conclusion, we suggest that a synergy between vitamin D and sex hormones could contribute to the age-related outcome of COVID-19.

Identifiants

pubmed: 34054557
doi: 10.3389/fphar.2021.683529
pii: 683529
pmc: PMC8155348
doi:

Types de publication

Journal Article

Langues

eng

Pagination

683529

Informations de copyright

Copyright © 2021 Peruzzu, Pagano, Pierdominici, Ruggieri, Antinori, D’Offizi, Petrosillo, Palmieri, Piselli, Boumis, Notari, Nicastri, Agrati, Ippolito, Gagliardi, Capobianchi and Ortona.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Rev Med Virol. 2020 Sep;30(5):e2119
pubmed: 32584474
Aliment Pharmacol Ther. 2020 Jul;52(2):409-411
pubmed: 32432810
J Clin Invest. 1989 Feb;83(2):537-42
pubmed: 2492309
Andrology. 2021 Jan;9(1):53-64
pubmed: 32524732
Eur J Endocrinol. 2012 Jan;166(1):77-85
pubmed: 22048968
Mol Med Rep. 2017 Nov;16(5):7432-7438
pubmed: 28944831
BMC Med. 2020 Nov 25;18(1):369
pubmed: 33234138
Ageing Res Rev. 2021 Jan;65:101205
pubmed: 33137510
Biochim Biophys Acta. 2011 Apr;1811(4):263-70
pubmed: 21262387
Front Endocrinol (Lausanne). 2020 Sep 30;11:567824
pubmed: 33101200
Sci Rep. 2020 Aug 19;10(1):14118
pubmed: 32814803
Endocrine. 2021 Feb;71(2):267-269
pubmed: 33452994
Andrology. 2021 Jan;9(1):65-72
pubmed: 32681716
Cell Death Discov. 2020 May 26;6:37
pubmed: 32499922

Auteurs

Daniela Peruzzu (D)

Center for Gender Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.

Maria Teresa Pagano (MT)

Center for Gender Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.

Marina Pierdominici (M)

Center for Gender Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.

Anna Ruggieri (A)

Center for Gender Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.

Andrea Antinori (A)

National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.

Gianpiero D'Offizi (G)

National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.

Nicola Petrosillo (N)

National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.

Fabrizio Palmieri (F)

National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.

Pierluca Piselli (P)

National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.

Evangelo Boumis (E)

National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.

Stefania Notari (S)

National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.

Emanuele Nicastri (E)

National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.

Chiara Agrati (C)

National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.

Giuseppe Ippolito (G)

National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.

Maria Cristina Gagliardi (MC)

Center for Gender Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.

Maria Rosaria Capobianchi (MR)

National Institute for Infectious Diseases, Lazzaro Spallanzani, IRCCS, Rome, Italy.

Elena Ortona (E)

Center for Gender Specific Medicine, Istituto Superiore di Sanità, Rome, Italy.

Classifications MeSH